Literature DB >> 32097922

A Decade of Experience with the Ovine Model of Myelomeningocele: Risk Factors for Fetal Loss.

Laura A Galganski1, Kaeli J Yamashiro2, Christopher D Pivetti2,3, Benjamin A Keller2, James C Becker2, Erin G Brown2,3, Payam Saadai2,3, Shinjiro Hirose2,3, Aijun Wang2,3,4, Diana L Farmer2,3.   

Abstract

INTRODUCTION: The ovine model is the gold standard large animal model of myelomeningocele (MMC); however, it has a high rate of fetal loss. We reviewed our experience with the model to determine risk factors for fetal loss.
METHODS: We performed a retrospective review from 2009 to 2018 to identify operative factors associated with fetal loss (early fetal demise, abortion, or stillbirth). Operative risk factors included gestational age at operation, operative time, reduction of multiple gestations, amount of replaced amniotic fluid, ambient temperature, and method of delivery.
RESULTS: MMC defects were created in 232 lambs with an overall survival rate of 43%. Of the 128 fetuses that died, 53 (42%) had demise prior to repair, 61 (48%) aborted, and 14 (11%) were stillborn. Selective reduction of multiple gestations in the same uterine horn was associated with increased fetal demise (OR 3.03 [95% CI 1.29-7.05], p = 0.01). Later gestational age at MMC repair and Cesarean delivery were associated with decreased abortion/stillbirth (OR 0.90 [95% CI 0.83-0.90], p = 0.03, and OR 0.37 [95% CI 0.16-0.31], p = 0.02), respectively.
CONCLUSION: Avoiding selective reduction, repairing MMC later in gestation, and performing Cesarean delivery decreases the rate of fetal loss in the ovine MMC model.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Animal disease models; Fetal research; Fetal surgery; Myelomeningocele; Spina bifida

Mesh:

Year:  2020        PMID: 32097922      PMCID: PMC7305949          DOI: 10.1159/000505400

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  29 in total

1.  Chorioamniotic membrane separation following open fetal surgery: pregnancy outcome.

Authors:  R Douglas Wilson; Mark P Johnson; Timothy M Crombleholme; Alan W Flake; Holly L Hedrick; Mary King; Lori J Howell; N Scott Adzick
Journal:  Fetal Diagn Ther       Date:  2003 Sep-Oct       Impact factor: 2.587

2.  Delayed intrauterine repair of an experimental spina bifida with a collagen biomatrix.

Authors:  A J Eggink; L A J Roelofs; W F J Feitz; R M H Wijnen; M M Y Lammens; R A Mullaart; H T B van Moerkerk; T H van Kuppevelt; A J Crevels; K Verrijp; F K Lotgering; P P van den Berg
Journal:  Pediatr Neurosurg       Date:  2007-12-14       Impact factor: 1.162

3.  In utero repair of experimental myelomeningocele saves neurological function at birth.

Authors:  M Meuli; C Meuli-Simmen; C D Yingling; G M Hutchins; G B Timmel; M R Harrison; N S Adzick
Journal:  J Pediatr Surg       Date:  1996-03       Impact factor: 2.545

4.  In utero surgery rescues neurological function at birth in sheep with spina bifida.

Authors:  M Meuli; C Meuli-Simmen; G M Hutchins; C D Yingling; K M Hoffman; M R Harrison; N S Adzick
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

5.  Creation of myelomeningocele in utero: a model of functional damage from spinal cord exposure in fetal sheep.

Authors:  M Meuli; C Meuli-Simmen; C D Yingling; G M Hutchins; K M Hoffman; M R Harrison; N S Adzick
Journal:  J Pediatr Surg       Date:  1995-07       Impact factor: 2.545

6.  Intrauterine repair of experimental surgically created dysraphism.

Authors:  D S Heffez; J Aryanpur; N A Rotellini; G M Hutchins; J M Freeman
Journal:  Neurosurgery       Date:  1993-06       Impact factor: 4.654

7.  Brain malformations in the sheep model of myelomeningocele are similar to those found in human disease: preliminary report.

Authors:  Jose Luis Encinas Hernández; C Soto; M A García-Cabezas; F Pederiva; M Garriboli; R Rodríguez; J L Peiró; F Carceller; M López-Santamaría; J A Tovar
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

8.  The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury.

Authors:  D S Heffez; J Aryanpur; G M Hutchins; J M Freeman
Journal:  Neurosurgery       Date:  1990-06       Impact factor: 4.654

9.  Human induced pluripotent stem cell-derived neural crest stem cells integrate into the injured spinal cord in the fetal lamb model of myelomeningocele.

Authors:  Payam Saadai; Aijun Wang; Yvette S Nout; Timothy L Downing; Katrine Lofberg; Michael S Beattie; Jacqueline C Bresnahan; Song Li; Diana L Farmer
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

10.  Fetal reconstructive surgery: experimental use of the latissimus dorsi flap to correct myelomeningocele in utero.

Authors:  C Meuli-Simmen; M Meuli; G M Hutchins; M R Harrison; H J Buncke; K M Sullivan; N S Adzick
Journal:  Plast Reconstr Surg       Date:  1995-10       Impact factor: 4.730

View more
  2 in total

1.  Preliminary Evaluation of a Novel Fetal Guinea Pig Myelomeningocele Model.

Authors:  Sarah C Stokes; Kaeli J Yamashiro; Melissa A Vanover; Laura A Galganski; Jordan E Jackson; Christina M Theodorou; Christopher D Pivetti; Diana Lee Farmer; Aijun Wang
Journal:  Biomed Res Int       Date:  2021-08-13       Impact factor: 3.411

2.  Efficacy of clinical-grade human placental mesenchymal stromal cells in fetal ovine myelomeningocele repair.

Authors:  Christina M Theodorou; Sarah C Stokes; Jordan E Jackson; Christopher D Pivetti; Priyadarsini Kumar; Kaeli J Yamashiro; Zachary J Paxton; Lizette Reynaga; Alicia A Hyllen; Aijun Wang; Diana L Farmer
Journal:  J Pediatr Surg       Date:  2021-06-05       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.